100mg (not mcg) x 30 capsules

1 capsule with 100 mg of SLU-PP 332 =

1000 capsules containing 100 mcg
500 capsules containing 200 mcg
400 capsules containing 250 mcg

This shop actually was opened because I realised that other shops charge about 200–400x for SLU-PP 332

SLU-PP 332, a synthetic small-molecule compound identified as a selective agonist of oestrogen-related receptors alpha and gamma (ERRα and ERRγ). SLU-PP 332 has attracted significant academic interest as a research tool for investigating the transcriptional regulation of mitochondrial biogenesis, fatty acid oxidation, and exercise-mimicking metabolic adaptations in in vitro and in vivo experimental models.

Chemical Profile

This product is a high-purity (>99%) powder. Unlike peptide compounds, SLU-PP 332 is a small-molecule research compound and is supplied in non-lyophilised powder form. It requires dissolution in an appropriate solvent prior to experimental use.

Component: SLU-PP 332
Total Quantity: 100 mg in 1 capsule
Purity: >99% (Determined by HPLC)

Quality Assurance

HPLC Analysis: Validated >99% purity.
Mass Spectrometry: Confirmed molecular weight and structure.
Toxicity: Not tested for human safety.

Research Context (Literature Review)

Note: The following is for educational purposes regarding the chemical properties of this compound and does not constitute a medical claim.

SLU-PP 332 acts as a pan-ERR agonist, with primary activity at ERRα and ERRγ. Both receptors are constitutively active orphan nuclear receptors that regulate the transcription of genes involved in oxidative phosphorylation, mitochondrial biogenesis, and fatty acid metabolism. In experimental models, ERRα and ERRγ activity is closely associated with the adaptive response of muscle tissue to sustained aerobic exercise.

In published in vitro studies, treatment of myocyte cell lines with SLU-PP 332 has been observed to upregulate the expression of genes including ESRRA, ESRRG, PGC-1α co-activator targets, and enzymes of the beta-oxidation pathway. Researchers have characterised this transcriptional profile as resembling the gene expression signature induced by endurance exercise in skeletal muscle.

In vivo research in rodent models has explored whether SLU-PP 332 treatment influences exercise capacity, metabolic rate, and body composition under controlled laboratory conditions. These studies remain at a preclinical stage. SLU-PP 332 is used in academic research as a pharmacological probe for dissecting ERR-mediated metabolic signalling.

Technical Specifications

Specification	Data
CAS Number	2088715-79-7
Molecular Formula	C22H18F3N3O3S
Molecular Weight	481.5 g/mol
Compound Class	Small-molecule ERR agonist
Appearance	White to pale yellow powder
Solubility	Soluble in DMSO (≥10 mM); limited aqueous solubility
Storage (Powder)	Store at -20°C, desiccated. Stable for up to 24 months.
Storage (Solution)	Store at -80°C. Avoid repeated freeze-thaw cycles.